Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Monmouth Junction, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

SEC filing history

Showing 526-550 of 1,000 matching filings.

Per page
25
Current page
22
CT ORDER File 001-36138

CT ORDER filing

Filing date
31 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Mar 2016
Reporting date
16 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-210285

S-8 filing

Filing date
18 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
11 Mar 2016
Reporting date
10 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Mar 2016
Reporting date
03 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2016
Reporting date
29 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36138

10-Q filing

Filing date
26 Feb 2016
Reporting date
31 Jan 2016
Next action
Verify source filing
4

4 filing

Filing date
25 Feb 2016
Reporting date
24 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80101

ADVAXIS, INC.

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80101

ADVAXIS, INC.

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80101

SC 13G

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-80101

SC 13G filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80101

SC 13G/A filing

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36138

DEFA14A filing

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36138

DEF 14A filing

Filing date
11 Feb 2016
Reporting date
11 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80101

ADXS AS OF 12/31/2015

Filing date
11 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
04 Feb 2016
Reporting date
03 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Feb 2016
Reporting date
29 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36138

PRE 14A filing

Filing date
01 Feb 2016
Reporting date
01 Feb 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .